Loading clinical trials...
Loading clinical trials...
It is a cross sectional observational study. It is to investigate whether AQP-1 polymorphism has any impact on fluid status in hemodialysis patients. The long term stable HD patients in the current ce...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
RenJi Hospital
NCT05654103 · End Stage Renal Disease on Dialysis
NCT05671991 · End Stage Renal Disease on Dialysis
NCT06842927 · End-Stage Kidney Disease, End Stage Renal Disease (ESRD), and more
NCT05735743 · End Stage Renal Disease on Dialysis
NCT05159999 · End Stage Renal Disease on Dialysis
Renji Hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions